BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 175924)

  • 1. Experimental models for DNA-RNA viral interactions: a brief review.
    Frankel JW
    Cancer Res; 1976 Feb; 36(2 pt 2):670-3. PubMed ID: 175924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of endogenous avian RNA tumor virus in Marek's disease lymphoblastoid cell lines and susceptibility of those lines to exogenous RNA tumor viruses.
    Nazerian K; Neiman P; Okazaki AW; Smith EJ; Crittenden LB
    Avian Dis; 1978; 22(4):732-41. PubMed ID: 219836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
    Baaten BJ; Butter C; Davison TF
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus.
    Eidson CS; Page RK; Kleven SH
    Avian Dis; 1978; 22(4):583-97. PubMed ID: 219826
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of expressions of endogenous (gs, chick helper factor) and exogenous avian RNA tumor viruses in the MOB-1 and MSB-1 lines derived from Marek's disease lymphomas.
    Ikuta K; Kato S; Ando T; Konobe T
    Biken J; 1976 Mar; 19(1):39-42. PubMed ID: 180970
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphoid neoplasms in chicken flocks free of infection with exogenous avian tumor viruses.
    Crittenden LB; Witter RL; Okazaki W; Neiman PE
    J Natl Cancer Inst; 1979 Jul; 63(1):191-200. PubMed ID: 221715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of macrophages in Marek's disease of the chicken.
    Powell PC; Hartley KJ; Mustill BM; Rennie M
    J Reticuloendothel Soc; 1983 Oct; 34(4):289-97. PubMed ID: 6312038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of isolator-derived and conventional chickens to Marek's disease herpesvirus and avian leukosis virus.
    Frankel JW; Farrow WM; Prickett CO; Smith ME; Campbell WF; Groupè V
    J Natl Cancer Inst; 1974 May; 52(5):1491-7. PubMed ID: 4364733
    [No Abstract]   [Full Text] [Related]  

  • 11. Nature of genetic resistance to Marek's disease in chickens.
    Lee LF; Powell PC; Rennie M; Ross LJ; Payne LN
    J Natl Cancer Inst; 1981 Apr; 66(4):789-96. PubMed ID: 6262555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting characteristics of Marek's disease herpesvirus isolated from chickens with and without avian leukosis virus infection.
    Campbell WF; Kufe DW; Peters WP; Spiegelman S; Frankel JW
    Intervirology; 1978; 10(1):11-23. PubMed ID: 204600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys.
    Schat KA; Calnek BW
    J Natl Cancer Inst; 1978 Sep; 61(3):855-7. PubMed ID: 211242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
    Lee LF; Liu X; Witter RL
    J Immunol; 1983 Feb; 130(2):1003-6. PubMed ID: 6184394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo events of retroviral long terminal repeat integration into Marek's disease virus in commercial poultry: detection of chimeric molecules as a marker.
    Davidson I; Borenshtain R
    Avian Dis; 2001; 45(1):102-21. PubMed ID: 11332471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marek's disease vaccines.
    Calnek BW
    Dev Biol Stand; 1982; 52():401-5. PubMed ID: 6299850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
    Omar AR; Schat KA
    Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity in Marek's disease: correlation of disease-related variables with immune responses in age-resistant chickens.
    Confer AW; Adldinger HK; Buening GM
    Am J Vet Res; 1980 Mar; 41(3):313-8. PubMed ID: 6245607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notes on the mechanism of postvaccination immunity in Marek's disease.
    Yakovleva LS; Mazurenko NP
    Neoplasma; 1977; 24(4):387-94. PubMed ID: 198688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of macrophages against Marek's disease virus plaque formation in chicken kidney cell cultures.
    Kodama H; Mikami T; Inoue M; Izawa H
    J Natl Cancer Inst; 1979 Nov; 63(5):1267-71. PubMed ID: 228107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.